The Revlon Carve-Out: Why Delaware’s Landmark PBC Ruling Gives Target Boards the Ultimate M&A Shield

The Death of the Inescapable Auctioneer

For nearly four decades, the bedrock of Delaware corporate law has been a single, uncompromising mandate: when a company’s board decides to sell control, its role shifts from a defender of the corporate bastion to an auctioneer charged with getting the absolute best price for stockholders. That doctrine, born in Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., 506 A.2d 173 (Del. 1986), has been the bane of target boards and the lifeblood of M&A plaintiffs’ lawyers.

But what happens when the target is a Public Benefit Corporation (PBC)? Can a board leave money on the table if a lower bidder promises to protect the environment, preserve jobs, or uphold a social mission? On July 29, 2026, the Delaware Court of Chancery finally answered the most debated theoretical question in modern corporate governance.

In a first-of-its-kind ruling, the Chancery Court held that public benefit corporations are explicitly exempt from the traditional Revlon duty to maximize shareholder value in a change-of-control transaction. This is not just a minor tweak to Delaware jurisprudence; it is a seismic shift. By ruling that PBC directors do not have to obtain the highest reasonable price in a sale, the Chancery Court has effectively handed founders and boards a judicially validated blueprint to bypass Revlon scrutiny altogether.

Balancing Over Bidding: The Law Behind the Loophole

To understand why this ruling matters to practicing deal lawyers, you have to look at the statutory architecture of the Delaware PBC. Under Del. Code Ann. tit. 8, § 365, directors of a PBC are required to balance three things: the pecuniary interests of the stockholders, the best interests of those materially affected by the corporation's conduct, and the specific public benefit identified in its certificate of incorporation.

Until now, plaintiffs’ attorneys argued that when a PBC enters a change-of-control transaction, the "pecuniary interest" prong must inevitably dominate. The logic was simple: once the company is sold, the existing shareholders are cashed out. They have no future interest in the company's social mission, so the only way to protect them is to maximize the payout. It was a clever attempt to force the Revlon square peg into the PBC round hole.

The Chancery Court forcefully rejected that premise.

"The statutory mandate of Section 365 does not evaporate upon the signing of a merger agreement. To impose a traditional Revlon duty of pure value maximization on a public benefit corporation would render the legislature's deliberate creation of this corporate form meaningless at the exact moment it is most heavily tested."

In short, a PBC board can legally accept a lower offer if they determine, in good faith, that the lower bidder will better preserve the company's stated public benefit. The board is no longer an auctioneer; it is a referee balancing a tripartite scale, and the court will defer to that balancing act so long as it is rational.

What This Means for M&A Practice

For corporate attorneys, this ruling fundamentally alters the M&A playbook. Here is what will happen next:

1. The Rise of the Defensive PBC Conversion
Expect a massive spike in traditional corporations attempting to convert to PBCs well ahead of anticipated sale processes. If a board knows an activist or a hostile acquirer is circling—one who will gut the company to maximize short-term cash flow—converting to a PBC provides the ultimate defensive shield. It allows the board to steer a future sale toward a "white knight" bidder who aligns with the company's mission, even if that bidder's per-share offer is lower. While converting to a PBC requires shareholder approval, founders with high-vote stock will increasingly utilize this mechanism.

2. The Plaintiff’s Dilemma
For plaintiffs' firms, enjoining a PBC merger just became exceptionally difficult. You can no longer rely on the classic Revlon claim that the board ran a flawed process that left money on the table. Instead, plaintiffs will have to attack the board's balancing process under § 365. Did the board actually investigate whether the lower bidder would uphold the public benefit? Were the directors conflicted? Proving a breach of fiduciary duty will require diving into the subjective, messy reality of how the board weighed social good against cash. It transforms an objective financial test into a highly subjective governance inquiry.

3. Buy-Side Diligence and Contractual Covenants
If you are representing a buyer acquiring a PBC, you cannot just win on price anymore. You must win on the mission. Deal lawyers will need to draft explicit, binding covenants in the merger agreement guaranteeing the continuation of the target's public benefit post-closing. The target board will need these covenants in the record to justify accepting your bid over a financially superior one. The "social impact" diligence is now just as legally critical as the financial diligence.

The Bottom Line

Delaware has definitively signaled that it will not let the gravitational pull of Revlon crush the statutory purpose of the Public Benefit Corporation. For the first time since 1986, there is a recognized, legal path for a target board to say, "We are selling the company, and we are intentionally taking less money."

For corporate practitioners, the era of the inescapable auctioneer is over. The era of the mission-driven sale has begun. Prepare your board decks accordingly.